The Antibody Society was formed in 2007 to further the broad interests of antibody engineering and antibody therapeutics, as well as to safeguard the public interest by increasing discussion and activities to create the safe, thorough testing of antibody therapeutics. The Society encompasses this increasingly diverse field, by supporting the superstructure for the engineering of recombinant antibodies, single scaffold binders, etc. through basic and applied research by those in academics and the private sector. The Society also seeks to provide a forum and voice for the thousands of people now working on all facets of this global field. Read our Mission Statement.
Special Antibody Issue PEDS March 2010
Submission deadline Dec 1 !The Antibody Society is pleased to announce that PEDS will feature a special Antibody Issue ! This will be the March 2010 Issue. The deadline for receipt of manuscripts is December 1at PEDS !
IBC’s Next Generation Protein Therapeutics SummitVisit Web
Date: June 21-23, 2010
Location: San Francisco Airport Marriott · San Francisco, CA
Data Standards, an exciting new development!Finally, 'The Guidelines for Information About Antibody Therapy Experiments (GIAATE)' are now available in a Tree format. After installation on your PC, you will be able to testrun the GIAATE tree. Find all info here !
The Antibody Society membership.The Antibody Society website is the vehicle for registration of new members, which is now possible via a secure online server,register here !
PEDS is the official journal of
The Antibody Society !
Antibody-focused Journals
(PubMed-indexed)
Broad coverage of all topics relevant to antibody research and development
Human IGG B12 anti-
primary HIV-1 isolates
(PDB: 1HZH)
MFE-23 anti-CEA scFv
(PDB: 1QOK)
Page last modified:
8 February, 2010 by Berend Tolner.
